Ami Fadia
Stock Analyst at Needham
(4.62)
# 197
Out of 5,117 analysts
379
Total ratings
54.45%
Success rate
29.99%
Average return
Main Sectors:
Stocks Rated by Ami Fadia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GHRS GH Research | Reiterates: Buy | $19 | $15.46 | +22.90% | 2 | Jan 5, 2026 | |
| AXSM Axsome Therapeutics | Maintains: Buy | $154 → $169 | $171.49 | -1.45% | 18 | Dec 31, 2025 | |
| COGT Cogent Biosciences | Reiterates: Hold | n/a | $34.26 | - | 24 | Dec 8, 2025 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $304 → $315 | $276.92 | +13.75% | 16 | Dec 8, 2025 | |
| HRMY Harmony Biosciences Holdings | Reiterates: Buy | $42 | $36.76 | +14.25% | 39 | Nov 24, 2025 | |
| DAWN Day One Biopharmaceuticals | Reiterates: Buy | $16 | $8.55 | +87.13% | 22 | Nov 24, 2025 | |
| RVMD Revolution Medicines | Maintains: Buy | $66 → $72 | $78.33 | -8.08% | 27 | Nov 6, 2025 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Buy | $28 → $29 | $26.15 | +10.90% | 12 | Nov 6, 2025 | |
| NBIX Neurocrine Biosciences | Maintains: Buy | $170 → $184 | $135.99 | +35.30% | 16 | Oct 29, 2025 | |
| ALKS Alkermes | Maintains: Buy | $43 → $44 | $27.99 | +57.20% | 4 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $8 | $1.64 | +389.30% | 10 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $21.50 | - | 37 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $3.87 | +210.08% | 1 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $13.58 | +106.19% | 1 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $6.61 | +66.41% | 20 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $174.63 | - | 43 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $202 | $174.39 | +15.83% | 34 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $23.02 | +52.04% | 1 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $29 | $6.61 | +338.73% | 21 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $240 → $320 | $13.50 | +2,270.37% | 2 | Feb 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $63 → $75 | $25.10 | +198.80% | 7 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $15 → $23 | $0.35 | +6,255.93% | 4 | Oct 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $63 | $14.17 | +344.60% | 5 | Sep 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $31.00 | - | 9 | Oct 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $22 | $1.24 | +1,674.19% | 4 | Jan 3, 2018 |
GH Research
Jan 5, 2026
Reiterates: Buy
Price Target: $19
Current: $15.46
Upside: +22.90%
Axsome Therapeutics
Dec 31, 2025
Maintains: Buy
Price Target: $154 → $169
Current: $171.49
Upside: -1.45%
Cogent Biosciences
Dec 8, 2025
Reiterates: Hold
Price Target: n/a
Current: $34.26
Upside: -
Praxis Precision Medicines
Dec 8, 2025
Maintains: Buy
Price Target: $304 → $315
Current: $276.92
Upside: +13.75%
Harmony Biosciences Holdings
Nov 24, 2025
Reiterates: Buy
Price Target: $42
Current: $36.76
Upside: +14.25%
Day One Biopharmaceuticals
Nov 24, 2025
Reiterates: Buy
Price Target: $16
Current: $8.55
Upside: +87.13%
Revolution Medicines
Nov 6, 2025
Maintains: Buy
Price Target: $66 → $72
Current: $78.33
Upside: -8.08%
ACADIA Pharmaceuticals
Nov 6, 2025
Maintains: Buy
Price Target: $28 → $29
Current: $26.15
Upside: +10.90%
Neurocrine Biosciences
Oct 29, 2025
Maintains: Buy
Price Target: $170 → $184
Current: $135.99
Upside: +35.30%
Alkermes
Oct 29, 2025
Maintains: Buy
Price Target: $43 → $44
Current: $27.99
Upside: +57.20%
Oct 28, 2025
Maintains: Buy
Price Target: $6 → $8
Current: $1.64
Upside: +389.30%
Oct 22, 2025
Downgrades: Hold
Price Target: n/a
Current: $21.50
Upside: -
Oct 13, 2025
Initiates: Buy
Price Target: $12
Current: $3.87
Upside: +210.08%
Oct 13, 2025
Initiates: Buy
Price Target: $28
Current: $13.58
Upside: +106.19%
Sep 30, 2025
Reiterates: Buy
Price Target: $11
Current: $6.61
Upside: +66.41%
Sep 24, 2025
Reiterates: Hold
Price Target: n/a
Current: $174.63
Upside: -
Aug 28, 2025
Reiterates: Buy
Price Target: $202
Current: $174.39
Upside: +15.83%
May 28, 2025
Initiates: Buy
Price Target: $35
Current: $23.02
Upside: +52.04%
May 2, 2025
Reiterates: Buy
Price Target: $29
Current: $6.61
Upside: +338.73%
Feb 1, 2021
Maintains: Outperform
Price Target: $240 → $320
Current: $13.50
Upside: +2,270.37%
Jan 21, 2021
Downgrades: Market Perform
Price Target: $63 → $75
Current: $25.10
Upside: +198.80%
Oct 1, 2020
Maintains: Market Perform
Price Target: $15 → $23
Current: $0.35
Upside: +6,255.93%
Sep 17, 2020
Maintains: Outperform
Price Target: $64 → $63
Current: $14.17
Upside: +344.60%
Oct 1, 2018
Upgrades: Market Perform
Price Target: n/a
Current: $31.00
Upside: -
Jan 3, 2018
Initiates: Outperform
Price Target: $22
Current: $1.24
Upside: +1,674.19%